LRIG1 and in situ carcinoma: Additionally, assessment of LRIG1 expression in a longitudinally characterised cohort of CIS lesions that either progressed to invasive LUSC or regressed [11] showed significantly lower LRIG1 levels in the progressive group (p=0.0086) (figure 4b).